Push to Cure Rare Diseases

March 9, 2010, 7:20 am by Wall Street Journal

Staff members at the Food and Drug Administration are doing something unusual. They are leaving Washington to help drug makers take a crucial step in developing drugs for rare diseases.

Read the full article

More from Wall Street Journal

Egg Inspectors Failed to Raise Alarms
Wall Street Journal : September 9, 2010, 8:40 am
U.S. Department of Agriculture experts found bugs and trash earlier this year on the Iowa farm at the center of the big recent egg recall, but didn't notify federal health authorities or

U.S. Rebukes Health Insurers
Wall Street Journal : September 9, 2010, 8:15 am
The Obama administration told health insurers that it will track those who enact "unjustified" rate increases and may block those companies from a new marketplace for insurance coverage.

Elan Pulls SEC Into Spat
Wall Street Journal : September 9, 2010, 7:20 am
In an unusual twist to a boardroom spat at Elan, the Irish biotech firm has reported one of its own directors to regulators at the SEC for potential insider-trading allegations.

FDA Boosts Warnings On Drugs Used in MRIs
Wall Street Journal : September 9, 2010, 4:02 am
The FDA said certain types of drugs used in MRI scans shouldn't be used in patients with kidney disease because of the risk of developing a rare and potentially fatal skin condition.

Health Outlays Still Seen Rising
Wall Street Journal : September 9, 2010, 3:44 am
The health-care overhaul enacted last spring won't significantly change national health spending over the next decade compared with projections before the law was passed.